| US 7,601,715 B2 | ||
| Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein | ||
| Nachimuthu Soundararajan, Kendall Park, N.J. (US); Yuping Qiu, Glastonbury, Conn. (US); Wenhao Hu, Princeton, N.J. (US); David R. Kronenthal, Yardley, Pa. (US); Pierre Sirard, St. Jean sur Richelieu (Canada); Jean Lajeunesse, Candiac (Canada); Robert Droghini, Candiac (Canada); Ramakrishnan Chidambaram, Pennington, N.J. (US); Xinhua Qian, Flemington, N.J. (US); Kenneth J. Natalie, Flemington, N.J. (US); Shawn K. Pack, Plainsboro, N.J. (US); Nathan Reising, Evansville, Ind. (US); Erqing Tang, Somerset, N.J. (US); Michael G. Fakes, Belle Mead, N.J. (US); Qi Gao, Wallingford, Conn. (US); Feng Qian, Hillsborough, N.J. (US); Blisse J. Vakkalagadda, North Brunswick, N.J. (US); Chiajen Lai, Kendall Park, N.J. (US); and Shan-Ming Kuang, Florence, S.C. (US) | ||
| Assigned to Bristol-Myers Squibb Company, Princeton, N.J. (US) | ||
| Filed on Jun. 19, 2006, as Appl. No. 11/455,338. | ||
| Claims priority of provisional application 60/693004, filed on Jun. 22, 2005. | ||
| Prior Publication US 2006/0293304 A1, Dec. 28, 2006 | ||
| Int. Cl. A01N 43/58 (2006.01); A61K 31/50 (2006.01); A61K 31/497 (2006.01); C07D 239/00 (2006.01); C07D 239/02 (2006.01); C07D 241/00 (2006.01); C07D 241/02 (2006.01); C07D 295/00 (2006.01) | ||
| U.S. Cl. 514—247 [514/252.12; 544/242; 544/336; 544/358] | 12 Claims |
1. A process for preparing compound IA having the structure
![]() R18 is H or alkyl;
R9, R10, R11, R12, R13, R14, R15 and R16 are each independently H or (C1-6)alkyl which may be optionally substituted with 1 to 3 same or different halogens;
which comprises reacting compound D having the structure
![]() ![]() wherein the reaction is carried out at a temperature within the range from about −10 to about 30° C. and
where in compounds D and IA, R2 is CH3O, R1 is H and R3 is H.
|